Newsletter

Subscribe and receive updates on this company

Text STOCKS to 72727 for mobile alerts

We are excited to present THC Farmaceuticals, Inc (OTC: CBDG).

Full DD Report for CBDG

You must become a subscriber to view this report.


Recent News from (OTC: CBDG)

Cannabis Sativa: All Hype
Introduction Next Tuesday, when all eyes will be on who will become the next President of the United States, there's another vote going on: on marijuana. Five states (California, Nevada, Maine, Massachusetts and Arizona) will vote on recreational marijuana laws, while four states (Florid...
Source: SeekingAlpha
Date: November, 07 2016 09:14
THC Farmaceuticals, Inc. Announces the Hiring of Ed Rosenthal as President
SCOTTSDALE, AZ / ACCESSWIRE / June 9, 2015 / THC Farmaceuticals, Inc. (OTCQB: CBDG): today announced that Ed Rosenthal, a noted horticulturist, author and publisher is joining CBDG as President of the Company, officially taking up his duties June 15th, 2015. Mr. Rosenthal has also agreed to ...
Source: ACCESSWIRE IA
Date: June, 09 2015 10:19
CORRECTION: THC Farmaceuticals, Inc. Announces the Hiring of Ed Rosenthal as President
CORRECTION: THC Farmaceuticals, Inc. Announces the Hiring of Ed Rosenthal as President
Source: OTC Markets
Date: June, 09 2015 00:00
THC Farmaceuticals, Inc. Announces the Hiring of Ed Rosenthal as PresidentTHC Farmaceuticals, Inc. Announces the Hiring of Ed Rosenthal as President
THC Farmaceuticals, Inc. Announces the Hiring of Ed Rosenthal as PresidentTHC Farmaceuticals, Inc. Announces the Hiring of Ed Rosenthal as President
Source: OTC Markets
Date: June, 09 2015 00:00
THC Farmaceuticals Announces Appointment of Former U.S. Senator Mike Gravel as Chief Executive Officer and Chairman of the Board
SCOTTSDALE, AZ / ACCESSWIRE / June 1, 2015 / THC Farmaceuticals, Inc. (OTCQB:CBDG): announces that on May 15, 2015, Former U.S. Senator Mike Gravel was appointed Chief Executive Officer of the Company and elected to serve on our board of directors as Chairman of the Board. Senator Gravel i...
Source: ACCESSWIRE IA
Date: June, 01 2015 17:21
City Media Name Change to THC Farmaceuticals Completed
SCOTTSDALE, AZ / ACCESSWIRE / May 22, 2015 / THC Farmaceuticals, Inc. (OTCQB: CBDG ), formerly known as City Media, Inc., today announces its name change to THC Farmaceuticals has been completed and accepted by FINRA as of April 8th, 2015. About THC Farmaceuticals, Inc.: CBDG owns and op...
Source: ACCESSWIRE IA
Date: May, 22 2015 12:00

 


About THC Farmaceuticals, Inc (OTC: CBDG)

Logo for THC Farmaceuticals, Inc (OTC: CBDG)

THC Farmaceuticals, Inc. focuses on placing ATMs that are owned and operated by the company in third party owned high traffic commercial areas.

 

Contact Information

 

 

Current Management

  • Mike Gravel / CEO
  • David Tobias / President
  • Greg Rubin / COO
  • Gary Henrie / Legal Counsel
  • Mike Gravel /

Current Share Structure

  • Market Cap: $6,111,864 - 03/09/2018
  • Authorized: 90,000,000 - 02/04/2015
  • Issue and Outstanding: 14,996,600 - 05/08/2015
  • Float: 623,500 - 02/04/2015

 


Recent Filings from (OTC: CBDG)

Quarterly Report - First Quarter Financial Statements 2017
Filing Type: Quarterly Report - First Quarter Financial Statements 2017Filing Source: OTC Markets
Filing Date: February, 20 2018
Quarterly Report - Fourth Quarter Financial Statements 2016
Filing Type: Quarterly Report - Fourth Quarter Financial Statements 2016Filing Source: OTC Markets
Filing Date: February, 20 2018
Quarterly Report - Third Quarter Financial Statements 2016
Filing Type: Quarterly Report - Third Quarter Financial Statements 2016Filing Source: OTC Markets
Filing Date: February, 20 2018
Quarterly Report - Second Quarter Financial Statements 2016
Filing Type: Quarterly Report - Second Quarter Financial Statements 2016Filing Source: OTC Markets
Filing Date: February, 20 2018
Quarterly Report - First Quarter Financial Statements 2016
Filing Type: Quarterly Report - First Quarter Financial Statements 2016Filing Source: OTC Markets
Filing Date: February, 20 2018
Certification of termination of registration of a class of security under Section 12(g) or notice of suspension of duty to file reports under Section 13 and 15(d) of the Act Section 12 (g).
Filing Type: 15-12GFiling Source: edgar
Filing Date: November, 29 2017
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: September, 03 2015
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: August, 19 2015
Amendment to a previously filed 10-Q
Filing Type: 10-Q/AFiling Source: edgar
Filing Date: August, 19 2015
Notification that form 10-Q will be submitted late
Filing Type: NT 10-QFiling Source: edgar
Filing Date: August, 14 2015

 

 


Daily Technical Chart for (OTC: CBDG)

Daily Technical Chart for (OTC: CBDG)


Stay tuned for daily updates and more on (OTC: CBDG)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (OTC: CBDG)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

OTC Report
@OTCReporter

 

 


Disclaimer: OTC Report publishes reports providing information on selected companies. OTC Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. OTC Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in CBDG is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. OTC Report has received up to $100,000 worth of crypto currency from a non-affiliated third party for the publication and circulation of this report. OTC Report does not own any shares of CBDG and does not buy, sell, or trade any shares of CBDG. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by OTC Report. All rights reserved. Our Full Disclaimer: http://otc.report/disclaimer/